For decades, the dominant explanation has been that cancer is primarily a genetic disease — a consequence of accumulated mutations in the DNA of a single cell. This idea has guided billions of dollars of research and shaped much of modern cancer therapy. Yet despite enormous scientific advances, the overall burden of cancer continues to rise, and many treatments remain toxic, expensive, and often only partially effective.
This reality forces us to ask an uncomfortable but necessary question: Have we been looking at cancer through the wrong lens?
In recent years, a growing body of scientific evidence has begun to challenge the traditional mutation-centric view of cancer. While genetic abnormalities are clearly present in tumors, they may not be the primary driver of the disease. Instead, many investigators are returning to a much older idea — first proposed nearly a century ago — that cancer may fundamentally be a disease of disordered cellular metabolism.
At the center of this idea lies the mitochondrion, the tiny energy-producing structure within every cell. When mitochondria function normally, cells generate energy efficiently and maintain tight control over growth and division. But when mitochondrial metabolism becomes impaired, cells may revert to more primitive metabolic programs that favor uncontrolled proliferation — the biological hallmark of cancer. This shift toward glucose-driven fermentation, even in the presence of oxygen, was first described by Otto Warburg in the 1920s and is now recognized as one of the most consistent features of cancer cells.
